AS, NH, MY, SM, GL, LJ, and SCS analyzed the data, and AS and GL wrote the manuscript
Comparing Dose Ranges and Goals Not everyone needs 2,000 mg
Alternative solutions, such as Canadian pharmacy products or compounded medications from med spas, sometimes offer savings, but there may be safety or efficacy concerns compared to the name-brand medications
There are a variety of unimolecular dual GLP-1/glucagon receptor (GLP-1/GCGR) agonists in clinical development, based on the native peptides (glucagon,GLP-1, oxyntomodulin, exendin), including cotadutide (MEDI0382) [23, 24], SAR425899 [25], pegamodutide (OPK88003), and efinopegdutide (HM12525A)
Currently, there is no effective etiological treatment for DAN, and management primarily focuses on alleviating clinical symptoms and improving patients quality of life